FDA Inspection 1076397 — Lupin Limited (Unit II)
The FDA completed an inspection of Lupin Limited (Unit II) on December 4, 2018 in Mandideep. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 4, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Mandideep (India)